EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Total body PET for radiopharmaceutical discovery

X Meng iD, R Wu, Z Yang

British Journal of Radiology · 01.09.2026 · 99 (1185) · 1716-1720

DOI: 10.1093/bjr/tqag086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Radiology, online erschienen am 22.04.2026. Verfasst von X Meng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation…. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Positron-Emission Tomography, Whole Body Imaging, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Capital Health Development Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a promising tool in clinical evaluation of radiopharmaceuticals, PET has been widely used in the molecular imaging pipeline, providing critical information for the decision-making process in each step of drug development. The advent of total body PET, characterized by its extended axial field of view and substantially increased sensitivity, represents a major technological leap. This innovation facilitates the direct translation of preclinical findings to human studies, enabling comprehensive, whole-body dynamic imaging for precise pharmacokinetic and dosimetric assessments in first-in-human trials. Furthermore, its high quantitative accuracy allows for the nuanced comparison of “me-too” or “me-better” compounds, revealing subtle yet critical differences in their in vivo behavior. This commentary reviews how these unique capabilities are transforming the clinical evaluation of radiopharmaceuticals, effectively bridging the gap between preclinical discovery and clinical application and accelerating the drug development pipeline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsPositron-Emission TomographyWhole Body ImagingDrug DiscoveryHumansAnimals

Stichwörter der Autor:innen

drug discoverymolecular imagingpharmacokineticsradiopharmaceuticalstotal body PET

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals, NMPA Key Laboratory for Research and Evaluat…
  • Beijing United Imaging Healthcare Co., Ltd., 9 Yongteng Bei Road, 100094, Beijing, China.

ORCID-Profile: X Meng

Förderung

  • National Natural Science Foundation of China
  • Capital Health Development Research Project

Zitieren

APA

Meng, X., Wu, R., & Yang, Z. (2026). Total body PET for radiopharmaceutical discovery. British Journal of Radiology, 99(1185), 1716-1720. https://doi.org/10.1093/bjr/tqag086

Vancouver

Meng X, Wu R, Yang Z. Total body PET for radiopharmaceutical discovery. British Journal of Radiology. 2026;99(1185):1716-1720. doi:10.1093/bjr/tqag086

BibTeX
@article{Meng2026,
  author = {Meng, X and Wu, R and Yang, Z},
  title = {Total body PET for radiopharmaceutical discovery},
  journal = {British Journal of Radiology},
  year = {2026},
  volume = {99},
  number = {1185},
  pages = {1716--1720},
  doi = {10.1093/bjr/tqag086}
}
Kostenlos starten →